FDA Inspection
Actavis Laboratories UT, Inc.Actavis Laboratories UT, Inc. – FDA Inspection, May 19, 2017
Record Details
This FDA Inspection record concerns Actavis Laboratories UT, Inc., with an inspection on May 19, 2017, issued by the Denver District Office, covering human drugs.
View Company Profile
ID · 5d4cbaa5-e36a-4b3c-be00-ba6f07176ee8
Inspection Facts
- Inspection number
- 1012979
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Actavis Laboratories UT, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2025 | VAI | Denver District Office | Drug Quality Assurance |
| March 19, 2024 | OAI | Drug Quality Assurance | |
| August 20, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 2, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 25, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Actavis Laboratories UT, Inc.
- FDA Inspection 1282698 - 2025-09-19
- FDA Inspection 1230375 - 2024-03-19
- FDA Inspection 1149636 - 2021-08-20
- FDA Inspection 1065736 - 2018-08-02
- FDA Inspection 1035181 - 2017-10-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.